Latest filing published 13 Oct 2026 for Mineralys Therapeutics, Inc., €70k. Read the official filing
Rodman David Malcom appears in our data through filings on Mineralys Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 16 filings, for trades running from 10 June 2026 to 13 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 13 October 2026, reports a transaction of €70k in Mineralys Therapeutics, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations